Public hearings for the Inquiry’s fourth investigation, into vaccines and therapeutics (Module 4), will be rescheduled.
The hearings were provisionally scheduled to take place in the summer of 2024. They will now take place at a later date,
to enable organisations to prioritise providing evidence for the Inquiry’s third investigation on the impact of the pandemic on healthcare (Module 3).
There will be no preliminary hearing for Module 4 on 8 February.